0001477932-23-007984.txt : 20231030 0001477932-23-007984.hdr.sgml : 20231030 20231030215151 ACCESSION NUMBER: 0001477932-23-007984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Duncan CENTRAL INDEX KEY: 0001888265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41555 FILM NUMBER: 231362113 MAIL ADDRESS: STREET 1: C/O ASP ISOTOPES INC., 433 PLAZA REAL STREET 2: SUITE 275 CITY: BOCA RATON STATE: FL ZIP: 33432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASP Isotopes Inc. CENTRAL INDEX KEY: 0001921865 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 872618235 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1101 PENNSYLVANIA AVENUE NW STREET 2: SUITE 300 CITY: WASHINGTON STATE: DC ZIP: 20004 BUSINESS PHONE: 202-756-2245 MAIL ADDRESS: STREET 1: 1101 PENNSYLVANIA AVENUE NW STREET 2: SUITE 300 CITY: WASHINGTON STATE: DC ZIP: 20004 4 1 form4.xml FORM 4 X0508 4 2023-08-10-05:00 false 0001921865 ASP Isotopes Inc. ASPI 0001888265 Moore Duncan C/O ASP ISOTOPES INC. 1101 PENNSYLVANIA AVENUE NW, SUITE 300 WASHINGTON DC 20004 true false false false false Common Stock 2023-08-10-05:00 4 A false 200000 0.00 A 750000 D Common Stock 2023-10-26-05:00 4 P false 104167 0.96 A 854167 D This special one-time equity award of 200,000 restricted shares was made in connection with the appointment of Mr. Moore to the Special Projects Committee of the board of Directors. Mr. Moore will vest in four equal installments every six months. Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities). /s/ Duncan Moore 2023-10-30-05:00